Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metabolic Effects of Carvedilol vs Atenolol in Hypertensive Patients with Type 2 Diabetes Mellitus
KCT0000974Phase 4Recruiting
- Sponsor
- Chong Kun Dang
- Start
- Feb 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of carvedilol, atenolol in hypertension (HTN), type 2 diabetes mellitus (T2DM), sponsored by Chong Kun Dang. Started Feb 2012; status: recruiting.
02
Drugs
carvedilolatenolol
03
Conditions
hypertension (HTN)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on KCT0000974.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0000974.